сряда, 20 март 2019 г.

Weekly Update: New diabetes clinical trial (10 items)

New diabetes clinical trial: Fracture Risk After Pancreas Transplantation (FraPaT)

Published on: March 11, 2019 at 06:00PM
Conditions:   Diabetes Mellitus, Type 1;   Fractures, Bone
Intervention:   Procedure: Pancreas transplantation alone
Sponsor:   Università Vita-Salute San Raffaele
Recruiting
https://clinicaltrials.gov/ct2/show/NCT03869281?term=diabetes&sfpd_d=14 March 11, 2019 at 05:50PM

via ClinicalTrials.gov


New diabetes clinical trial: An Artificial Intelligence Assisted Telehealth Intervention to Promote Self-Management in Patients With Type 2 Diabetes Mellitus (Qualitative Interview)

Published on: March 11, 2019 at 06:00PM
Condition:   Diabetes Mellitus
Intervention:   Behavioral: Semi-structured Interview
Sponsor:   University of Alabama at Birmingham
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT03868813?term=diabetes&sfpd_d=14 March 11, 2019 at 05:50PM

via ClinicalTrials.gov


New diabetes clinical trial: Women and Risk of Type 2 Diabetes

Published on: March 12, 2019 at 06:00PM
Condition:   Type 2 Diabetes Mellitus
Intervention:  
Sponsors:   University of Oslo;   Norwegian Diabetes Association
Enrolling by invitation
https://clinicaltrials.gov/ct2/show/NCT03870724?term=diabetes&sfpd_d=14 March 12, 2019 at 05:42PM

via ClinicalTrials.gov


New diabetes clinical trial: Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial

Published on: March 12, 2019 at 06:00PM
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Diabetes Medicines;   Drug: Dapagliflozin
Sponsor:   Mackay Memorial Hospital
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT03871621?term=diabetes&sfpd_d=14 March 12, 2019 at 05:42PM

via ClinicalTrials.gov


New diabetes clinical trial: Influenza Vaccination Digital Interventions for People Living With Diabetes

Published on: March 12, 2019 at 06:00PM
Condition:   Diabetes
Interventions:   Behavioral: Diabetes Digital Intervention;   Behavioral: Generic Digital Intervention
Sponsor:   Evidation Health
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT03870997?term=diabetes&sfpd_d=14 March 12, 2019 at 05:42PM

via ClinicalTrials.gov


New diabetes clinical trial: Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine

Published on: March 14, 2019 at 06:00PM
Condition:   Type 1 Diabetes Mellitus
Interventions:   Drug: Insulin Aspart SAR341402;   Drug: Insulin Aspart;   Drug: Insulin glargine U100
Sponsor:   Sanofi
Recruiting
https://clinicaltrials.gov/ct2/show/NCT03874715?term=diabetes&sfpd_d=14 March 14, 2019 at 03:42PM

via ClinicalTrials.gov


New diabetes clinical trial: Effect of Empagliflozin on Body Composition and Ketones

Published on: March 15, 2019 at 06:00PM
Conditions:   Diabetes Mellitus;   Fat; Intolerance, Pancreas
Interventions:   Drug: Empagliflozin 10 MG;   Drug: Hypoglycemics Oral
Sponsor:   Seoul National University Bundang Hospital
Recruiting
https://clinicaltrials.gov/ct2/show/NCT03877406?term=diabetes&sfpd_d=14 March 15, 2019 at 06:59PM

via ClinicalTrials.gov


New diabetes clinical trial: A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK)

Published on: March 15, 2019 at 06:00PM
Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: Semaglutide
Sponsor:   Novo Nordisk A/S
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT03876015?term=diabetes&sfpd_d=14 March 15, 2019 at 06:59PM

via ClinicalTrials.gov


New diabetes clinical trial: Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab

Published on: March 15, 2019 at 06:00PM
Condition:   Type 1 Diabetes Mellitus
Interventions:   Biological: teplizumab;   Biological: Placebo
Sponsor:   Provention Bio, Inc.
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT03875729?term=diabetes&sfpd_d=14 March 15, 2019 at 06:59PM

via ClinicalTrials.gov


New diabetes clinical trial: Myo-inositol for Reduction of Insulin Therapy in Gestational Diabetes Mellitus

Published on: March 15, 2019 at 06:00PM
Condition:   Gestational Diabetes Mellitus
Interventions:   Dietary Supplement: Myo Inositol;   Other: Placebo
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT03875755?term=diabetes&sfpd_d=14 March 15, 2019 at 06:59PM

via ClinicalTrials.gov


Няма коментари:

Публикуване на коментар